Allurion Technologies ALUR.WS
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of Allurion Technologies (ALUR.WS)
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Key Insights
Critical company metrics and information
Latest Closing Price
$0.029Price-Earnings Ratio
-0.07Total Outstanding Shares
64.37 Million SharesTotal Employees
24Dividend
No dividendIPO Date
August 2, 2023SIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
New York Stock ExchangeType
WarrantHeadquarters
11 huron dr ste 200, Natick, MA, 01760Homepage
https://www.allurion.com
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $-147,000 |
| Net Cash Flow From Operating Activities | $-49.90 Million |
| Net Cash Flow From Operating Activities, Continuing | $-49.90 Million |
| Net Cash Flow From Financing Activities | $-147,000 |
| Net Cash Flow | $-51.05 Million |
| Net Cash Flow From Investing Activities, Continuing | $-1.01 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Benefits Costs and Expenses | $59.13 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Research and Development | $19.32 Million |
| Operating Expenses | $84.22 Million |
| Operating Income/Loss | $-58.82 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $-24.76 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $-21.87 Million |
| Other Comprehensive Income/Loss | $2.89 Million |
| Comprehensive Income/Loss Attributable To Parent | $-21.87 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Other Non-current Assets | $2.79 Million |
| Equity Attributable To Noncontrolling Interest | $0 |
| Equity | $-64.79 Million |
| Fixed Assets | $3.08 Million |
| Temporary Equity | $979,000 |
| Other Current Liabilities | $8.85 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Recent Headlines From The Web
Latest news, press releases, and media coverage about ALUR.WS from trusted financial sources
ⓒ 2025 Financhle. All Rights Reserved.